实用肝脏病杂志 ›› 2020, Vol. 23 ›› Issue (1): 102-105.doi: 10.3969/j.issn.1672-5069.2020.01.028

• 肝癌 • 上一篇    下一篇

肝部分切除术患者目标导向性液体治疗疗效及安全性研究*

马宁, 戴晓雯, 吴建江   

  1. 830054 乌鲁木齐市 新疆医科大学第一附属医院麻醉科
  • 收稿日期:2019-03-08 发布日期:2020-01-14
  • 通讯作者: 吴建江,E-mail:wuyunjs06@163.com
  • 作者简介:马宁,男,38岁,大学本科,主治医师。E-mail:xjmn08@163.com
  • 基金资助:
    新疆维吾尔自治区自然科学基金资助项目(编号:2015211C096)

Influence of different types of liquid infusion on clinical efficacy and safety of patients withhepatocellular carcinoma undergoing partial hepatectomy

Ma Ning, Dai Xiaowen , Wu Jianjiang   

  1. Department of Anesthesiology,First Affiliated Hospital,Xinjiang Medical University,Urumqi 830000,Xinjiang Uygur Autonomous Region,China
  • Received:2019-03-08 Published:2020-01-14

摘要: 目的 探讨晶体液和胶体液对目标导向性液体治疗(GDFT)下行肝部分切除术治疗的肝细胞癌(HCC)患者疗效及安全性的影响。方法 2017年10月~2018年10月我院收治的HCC患者90例,在接受肝部分切除术麻醉过程中,随机将患者分为对照组30例、晶体组30例和胶体组30例,分别采用常规液体管理或GDFT下晶体液和胶体液快速输注,术中监测中心性静脉血氧饱和度(ScvO2)、血乳酸(lactate,Lac)和血糖(Glu)水平。结果 胶体组肛门排气时间、下床活动时间和术后住院日分别为(55.8±8.3)h、(3.4±0.5)d和(7.8±1.5)d,晶体组分别为(54.7±8.0)h、(3.6±0.7)d和(8.1±1.7)d,均显著短于对照组的(62.3±10.1)h、(4.6±0.9)d和(10.2±2.6)d(P <0.05);在T3和T4时,胶体组ScvO2水平分别为(83.7±7.1)%和(84.2±7.5)%,晶体组分别为(82.1±7.8)%和(82.5±8.0)%,均显著优于对照组的(76.4±6.7)%和(74.9±5.4)%(P <0.05),在T2、T3和T4,胶体组Lac水平分别为(1.3±0.3)mmol/L、(1.7±0.4)mmol/L和(1.8±0.4)mmol/L,晶体组分别为(1.4±0.2)mmol/L、(1.8±0.4)mmol/L和(1.9±0.5)mmol/L,均显著低于对照组的(1.7±0.3)mmol/L、(2.2±0.5)mmol/L和(2.6±0.7)mmol/L(P <0.05),胶体组Glu水平分别为(5.5±0.8)mmol/L、(7.0±1.3)mmol/L和(6.8±1.1)mmol/L,晶体组分别为(5.6±0.7)mmol/L、(7.1±1.0)mmol/L和(7.2±1.2)mmol/L,均显著优于对照组的(6.3±1.1)mmol/L、(8.4±1.7)mmol/L和(8.2±1.4)mmol/L(P <0.05);在术后5 d,胶体组和晶体组血清ALT水平分别为(65.3±7.6)U/L和(68.3±7.4)U/L,均显著低于对照组的(123.4±15.3)U/L(P <0.05);胶体组恶心呕吐发生率为6.7%,显著低于其他两组的33.3%和26.7%(P<0.05)。结论 与常规液体管理方案比,在GDFT下行肝部分切除术过程中采取晶体和胶体输注可有效加快术后康复进程,增加组织血流灌注,有助于保护肝脏功能。

关键词: 肝细胞癌, 肝部分切除术, 目标导向性液体治疗, 晶体液, 胶体液, 麻醉

Abstract: Objective The aim of this study was to investigate the influence of crystal and colloidal liquid infusion base on goal-directed fluid therapy (GDFT) during anesthesia on clinical efficacy and safety in patients with hepatocellular carcinoma (HCC) undergoing partial hepatectomy. Methods 90 patients with HCC were enrolled in our hospital between October 2017 and October 2018, and all patients underwent partial hepatectomy. The patients were randomly divided into 3 groups including control (n=30) with conventional liquid management, colloidal group (n=30) with fast filling of colloid liquids and crystal group (n=30) with fast filling of crystal liquids during anesthesia. The central venous oxygen saturation (ScvO2), as well as blood lactate (Lac) and glucose (Glu) levels were monitored. Results The time of first exhaust, time of early ambulation, and hospitalization stay after operation in colloidal group were (55.8±8.3)h, (3.4±0.5)d and(7.8±1.5)d, in crystal liquid group were (54.7±8.0)h, (3.6±0.7)d and (8.1±1.7)d, all significantly shorter than (62.3±10.1)h, (4.6±0.9)d and (10.2±2.6)d(P <0.05) in the control; at T3 and T4, the ScvO2 in colloidal group was (83.7±7.1)% and (84.2±7.5)%, in crystal liquid group was (82.1±7.8)% and (82.5±8.0)%, all superior to (76.4±6.7)% and (74.9±5.4)%(P <0.05), respectively, in the control, at T2, T3 and T4, blood Lac levels in the colloidal group were (1.3±0.3)mmol/L, (1.7±0.4)mmol/L and (1.8±0.4)mmol/L, in crystal liquid group were (1.4±0.2)mmol/L,(1.8±0.4)mmol/L and (1.9±0.5)mmol/L, all much lower than (1.7±0.3)mmol/L,(2.2±0.5)mmol/L and (2.6±0.7)mmol/L(P <0.05), respectively, in the control, and blood Glu levels in the colloidal fluid group were (5.5±0.8)mmol/L, (7.0±1.3)mmol/L and (6.8±1.1)mmol/L, in crystal fluid group were (5.6±0.7)mmol/L, (7.1±1.0)mmol/L and (7.2±1.2)mmol/L, all superior to (6.3±1.1)mmol/L,(8.4±1.7)mmol/L and (8.2±1.4)mmol/L(P <0.05), respectively, in the control; on day five of post-operation, serum ALT levels in colloidal and crystal liquid groups were (65.3±7.6)U/L and (68.3±7.4)U/L, both significantly lower than (123.4±15.3)U/L(P <0.05) in the control; the incidence of nausea and vomiting after operation in colloidal group was6.7%, significantly lower than 33.3% and 26.7%(P<0.05) in other two groups. Conclusion Compared with conventional liquid management, the application of crystal and colloidal liquid infusion under the guidance of goal-directed fluid therapy in patients with HCC undergoing partial hepatectomy could efficiently accelerate the recovery of health after operation, which might be related to the increase of tissue perfusion and liver function protection. Fast filling of colloidal liquids might reduce the risk incidence of nausea and vomiting after operation.

Key words: Hepatoma, Partial hepatectomy, Crystal fluid, Colloidal fluid, Goal-directed fluid therapy, Anesthesia